Granulocyte Colony-Stimulating Factor-Producing Gallbladder Cancer by Kanaya, Nobuhiko et al.
G ranulocyte colony-stimulating factor (G-CSF) is a cytokine associated with granulocytosis.  
G-CSF-producing malignant tumors have been diag-
nosed in various organs,  including the lungs,  colon,  
gallbladder,  and stomach [1-3].  G-CSF-producing 
tumors exhibit signiﬁcant hyperplastic and metastatic 
properties,  and have a very poor prognosis [4].  
Interestingly,  most cases of G-CSF-producing tumors 
have been reported in Japan.  Here,  we report a rare 
case of a G-CSF-producing gallbladder tumor in a 
middle-aged female who has survived without recur-
rence for 48 months after surgery.
Case Report
　 A 47-year-old female visited a gynecological clinic 
approximately one month after developing fever and 
general fatigue.  She was not diagnosed with a gyneco-
logical disorder at that time,  although abdominal 
ultrasonography (US) revealed a mass in the gallblad-
der; thus,  she was referred to our institution.  The 
patient reported a 3-kg weight loss over the past few 
months.  On a physical examination,  her body tem-
perature was 38℃.  An approximately 10-cm-diame-
ter mass was found in the upper right quadrant of the 
abdomen,  with slight tenderness.  Laboratory test 
results revealed leukocytosis (21,200 cells/µl) with 
83.8  granulocytes and a platelet count of 67.6×
104/µl.  The C-reactive protein level was 17.27 mg/dl.  
Although the serum aspartate aminotransferase level 
was normal,  the alanine aminotransferase and alkaline 
phosphatase levels were elevated at 29 and 1,017 U/l,  
respectively.  Levels of the tumor markers carcinoem-
bryonic antigen and carbohydrate antigen 19-9 were 
normal; however,  the interleukin (IL)-2 receptor 
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level was markedly elevated at 2,290 U/ml (normal 
range: 145-519 U/ml).  Abdominal US showed an 
enlarged gallbladder and the presence of a heteroge-
neous mass occupying the body and fundus.  Contrast-
enhanced computed tomography (CT) showed an 
enhanced solid mass in the gallbladder measuring 
8.5×8.0 cm (Fig.  1A) and a cystic ductal lymph node 
with a diameter of approximately 4.0 cm.  This lymph 
node was compressing the second part of the duode-
num (Fig.  1B).  Magnetic resonance cholangiopan-
creatography showed no pancreaticobiliary malforma-
tions,  stenosis,  or irregularity of the bile duct.  On 
endoscopic ultrasound-guided ﬁne needle aspiration,  
the tumor was suspected as a lesion of undiﬀerenti-
ated carcinoma of the gallbladder.  Prior to surgery,  
the patientʼs fever did not improve with antibiotics.  
The cause of these symptoms was suspected to be 
cytokine production by the tumor cells.  Therefore,  
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Fig. 2　 Histological images.  (A) HE staining.  Papillary adenocarcinoma with a sarcomatoid component.  (B) Immunohistochemical 
staining.  The specimen was positive for G-CSF.
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Fig. 1　 CT images.  (A) A contrast-enhanced computed tomography scan showing an enhanced,  8.5×8.0-cm,  solid lesion in the gall-
bladder.  (B) Another solid mass adjacent to the main tumor,  approximately 4.0 cm in size,  was suspected as a cystic ductal lymph node,  
which was compressing the second portion of the duodenum.
the serum G-CSF level was measured and subse-
quently found to be elevated at 82.1 pg/ml (normal 
range＜39.0 pg/ml).
　 The patient underwent resection of hepatic 
S4a＋S5 and regional lymph node dissection,  along 
with partial resection of the duodenum.  The extrahe-
patic bile duct was not resected,  since the intraopera-
tive histological examination of the cystic duct showed 
a negative surgical margin and the lymph nodes around 
the bile duct appeared to be negative for metastasis.  
Curative resection was achieved.  The resected gall-
bladder specimen contained a tumor,  10 cm in size,  
occupying the body and fundus.  A cross-section 
revealed a solid mass with central necrosis.  Histologi-
cally,  the tumor was composed of undiﬀerentiated 
carcinoma with spindle and giant cells,  as well as 
papillary adenocarcinoma.  The undiﬀerentiated carci-
noma component comprised almost the complete area 
of the tumor (Fig.  2A).  Immunohistochemically,  part 
of the undiﬀerentiated carcinoma was positive for the 
cytokeratin markers AE1/3 and CAM5.2,  and nega-
tive for other markers,  such as c-kit,  CD34 and 
S-100.  The mass was positive for G-CSF (Fig.  2B).  
Pathologically,  the tumor had invaded the duodenal 
wall.  Another mass adjacent to the main tumor was 
identiﬁed as the only lymph node presenting metasta-
sis.  The stage of the gallbladder cancer at resection 
was considered to be Stage IIIB,  T3N1M0 (UICC-7).  
Postoperatively,  the patientʼs leukocyte count and 
body temperature dramatically decreased to normal 
levels (Fig.  3).  By the time of discharge,  approxi-
mately 2 weeks after surgery,  the serum G-CSF and 
IL-2 receptor concentrations had also decreased to 
20.9 pg/ml and 388 U/ml,  respectively.  Adjuvant 
gemcitabine chemotherapy was administered for 16 
months.  The patient was followed-up with CT scans 
every 6 months after chemotherapy.  No postoperative 
recurrence had occurred at 48 months.
Discussion
　 G-CSF-producing tumors were ﬁrst reported by 
Asano in 1977 and were initially found in the lung [5].  
These tumors are rarely detected in cases of gallblad-
der cancer.  G-CSF-producing tumors often secrete 
cytokines,  such as IL-1 and IL-6.  Therefore,  aﬀected 
patients present with fever and leukocytosis.  The 
current patient had a high fever and leukocytosis on 
admission; however,  no pathogens were detected and 
her symptoms did not improve with antibiotics.  
Cholecystitis and other diseases were ruled out,  and 
G-CSF-producing gallbladder cancer was suspected.  
The diagnostic criteria for G-CSF-producing tumors 
recommended by Asano include four factors: (i) leuko-
cytosis with an unknown cause,  (ii) elevated serum 
G-CSF level,  (iii) decreased leukocyte count and 
serum G-CSF level after tumor resection,  and 
(iv) proof of G-CSF production in the tumor [5].  The 
present patient met all 4 criteria.  
　 In the Japanese literature,  we found 22 patients 
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Fig. 3　 Clinical course.  Changes in the leukocyte count (dot) and body temperature (line) in the present case.  AD,  admission; OP,  
operation; ENT,  discharge; WBC,  white blood cells; BT,  body temperature.
with gallbladder cancer producing G-CSF reported 
from 1983 to 2014 [6,7].  The male: female ratio 
was 8 : 14.  The mean age at diagnosis was 67.4 
(range,  47-82) years,  with the current patient being 
the youngest.  The mean leukocyte count and serum 
G-CSF level on admission were 31,809 cells/µl and 
234 pg/ml,  respectively.  These blood parameters can 
be helpful for diagnosing G-CSF-producing tumors and 
are also useful as markers of recurrence and tumor 
exacerbation.  The mean tumor size at diagnosis was 
96.9 (range,  45-130) mm.  Histological examinations 
of the specimens demonstrated 6 cases of undiﬀerenti-
ated or poorly diﬀerentiated adenocarcinoma,  6 cases 
of adenosquamous carcinoma,  3 cases of pleomorphic 
giant cell carcinoma,  3 cases of moderately diﬀerenti-
ated adenocarcinoma,  2 cases of squamous cell carci-
noma,  and three others.  Only three of these 22 cases 
were common types of adenocarcinoma.  The prognoses 
among these cases were generally poor.  Eight of 22 
patients could not undergo surgery,  and 15 of the 22 
patients died within 6 months.  This is partly because 
of the characteristics of diﬀerentiation.  G-CSF-
producing gallbladder cancer tends to exhibit high 
biological malignancy.  Despite the poor general prog-
nosis,  some patients achieve long-term survival follow-
ing curative resection.  The 2 most important factors 
for improving the prognosis of G-CSF-producing gall-
bladder cancer are early diagnosis and curative resec-
tion.  
　 Although the signiﬁcance of postoperative adjuvant 
chemotherapy for gallbladder carcinoma remains con-
troversial,  it might be useful for treating gallbladder 
carcinoma according to the results of a phase III mul-
ticenter prospective randomized controlled trial con-
ducted by Takada et al.  [8].  Also,  in a study of biliary 
tract cancer,  Valle et al.  [9] reported that therapy 
with cisplatin plus gemcitabine was associated with a 
signiﬁcant survival advantage,  compared with gemcit-
abine monotherapy alone.  Adjuvant chemotherapy 
trials using gemcitabine,  capecitabine,  S-1,  and com-
bination chemotherapy with platinum agents are cur-
rently underway.  Adjuvant chemotherapy was per-
formed in the present patient because of the poor 
prognosis and the discovery of metastasis in a lymph 
node.
　 In summary,  for patients with gallbladder cancer 
exhibiting high fever and leukocytosis,  G-CSF-
producing gallbladder cancer should be included as 
a diﬀerential diagnosis.  Although G-CSF-producing 
gallbladder cancer demonstrates high biological malig-
nancy and is associated with a poor prognosis,  cura-
tive resection,  when possible,  may contribute to long-
term survival.
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